Related Experiment Video

Updated: Aug 16, 2026

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases
09:36

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases

Published on: June 28, 2019

Potential role of calmodulin-dependent phosphodiesterase in human brain tumor (review)

Shankar B Das1, Rajendra K Sharma

  • 1Cancer Research Unit, Saskatchewan Cancer Agency, 20 Campus Drive, University of Saskatchewan, Saskatoon, SK S7N 4H4, Canada.

Oncology Reports
|September 6, 2005
PubMed

Insights

Calmodulin-dependent phosphodiesterase (PDE1) is present in normal brain regions but significantly reduced in glioblastoma multiforme (GBM) tumors. Further research is needed on PDE1 inhibitors found in GBM tissue.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Oncology

Background:

  • Calmodulin-dependent phosphodiesterase (PDE1) is well-characterized in normal mammalian tissues.
  • Its role and expression in human brain tumors, specifically glioblastoma multiforme (GBM), remain largely unexplored.
  • PDE1 is known to be localized across various normal brain regions.

Purpose of the Study:

  • To review laboratory findings on the potential role of PDE1 in GBM.
  • To investigate the expression levels of PDE1 in GBM compared to normal brain tissue.
  • To explore the significance of PDE1 inhibitors discovered within tumor tissue.

Main Methods:

  • Literature review of laboratory work on PDE1 in GBM.
  • Comparative analysis of PDE1 localization and concentration in normal brain versus GBM tissue.
  • Identification and characterization of potential PDE1 inhibitors in GBM.

Main Results:

  • PDE1 is widely distributed in normal brain structures like the cerebrum, diencephalon, brainstem, and cerebellum.
  • Specific high-concentration areas in the normal brain include the striatum, globus pallidus, substantia nigra, subiculum, Purkinje cells, and cerebral cortex.
  • PDE1 expression is markedly lower in GBM tissue compared to normal cerebral cortex.

Conclusions:

  • PDE1 exhibits differential expression in GBM, being significantly reduced compared to normal brain.
  • The presence of an inhibitor in GBM tissue suggests a potential interaction with PDE1 that warrants further investigation.
  • Understanding PDE1's role in GBM could open new avenues for therapeutic strategies.

More Related Videos

Pull-down of Calmodulin-binding Proteins07:51

Pull-down of Calmodulin-binding Proteins

Published on: January 23, 2012

Related Concept Videos

Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...